LUXRX

What this means for you

This application is over — abandoned 30 Jun 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

98043421

Mark type

Stylized text

Filed

15 Jun 2023

Abandoned

30 Jun 2025

Goods and services

• Class 005 — Pharmaceuticals: Medicated liquid soaps; Medicated balms for treatment of skin care, pain management, discomfort, ache, muscle and joint; Medicated candies; Medicated candy; Medicated chewing gum; Medicated compresses; Medicated cosmetics; Medicated creams for treating dermatological conditions; Medicated dermatological preparations and substances; Medicated diaper rash cream; Medicated diaper rash lotions; Medicated diaper rash ointment; Medicated diaper rash ointments and lotions; Medicated facial cleansers; Medicated foot bath preparations; Medicated grooming preparations for hair care, skin care, etc., namely, hair loss and skin complexion; Medicated lotions for sunburn; Medicated lotions for treating dermatological conditions; Medicated lotions for skin care, pain management, discomfort, ache, muscle and joint; Medicated lozenges; Medicated make-up; Medicated massage oils; Medicated moisturizers; Medicated mouthwash; Medicated mouthwash for treating gingivitis; Medicated oils containing cannabis, herbs, hemp, extracts, vitamins; Medicated ointments for treating dermatological conditions; Medicated pre-moistened tissues; Medicated serums for treatment of skin care, pain management, discomfort, ache, muscle and joint; Medicated shampoo; Medicated shampoos; Medicated skin care preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated skin preparation for use in treating pain, discomfort, muscle ache; Medicated skin soap; Medicated skin toners; Medicated soap; Medicated soap for foot perspiration; Medicated sun block; Medicated sun screen; Medicated sunburn lotions; Medicated sunburn ointments; Medicated sunscreen; Medicated sweets; Medicated toothpaste; Medicated topical solution that increases the efficacy and percutaneous absorption of benzoyl peroxide; Medicated wart removing preparations; Syrups for pharmaceutical purposes for the treatment of coug, itc.h, cold, pain, discomfort; Acne medications; Allergy medication; Allergy medications; Allergy relief medication; Ampoules sold filled with medicated serums for treatment of dermatological conditions; Burn relief medication; Candy, medicated; Cough syrups; Cough syrups for medical use; Diarrhea medication; Fungal medications; Medicinal syrups containing each or all of the following in various combinations: cannibis and hemp extract, herbs, vitamins, medications for the treatment of any condition including but not limited to cough, cold, ache and pain, skin conditions and etc.; Medicinal syrups for the treatment of skin conditions, aches and pains; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Non-medicated topical gel for the prevention and treatment of allergies; Non-medicated topical gel for the prevention and treatment of cold and flu; Non-medicated, therapeutic skin creams for the treatment of skin care, pain management, discomfort, ache, muscle and joint; Nutritional supplements in the form of syrups, pills, capsules, ointments, creams, etc.; Pain relief medication; Plant and herb extracts sold as components of medicated cosmetics; Stimulatory medications for use in weight reduction programs; Transdermal patches featuring cannabis and hemp extract with or without other ingredients, including medications, herbs and vitamins; Veterinary preparations, namely, pain relief medication

Owner

• Davidson, Daniel Shane Sheibani, Los Angeles, CA, US

Prosecution history

• 26 Jul 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 26 Jul 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 27 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 27 Mar 2025 — NON-FINAL ACTION E-MAILED
• 27 Mar 2025 — NON-FINAL ACTION WRITTEN
• 25 Mar 2025 — ASSIGNED TO EXAMINER
• 19 Jul 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 19 Jun 2023 — NEW APPLICATION ENTERED